• 97362+ Medical Conferences
  • 210 Specialties
  • 17378 Organizers
  • 119664 Speakers
  • 149 Countries
  • 3763 Cities
32454+
CME Conference Registrations Sold
Home  >  Speakers  >  Mark A. Behlke
Mark A. Behlke

Mark A. Behlke

Chief Scientific Officer | Coralville, Iowa    United States of America
Biotechnology
Biotechnology, Research And Development,...More
Spoken at 4 events

Biography :

Dr. Behlke has directed research activities at IDT since joining the company in 1995 with a focus on novel molecular biology applications of oligonucleotide-based technologies. In addition, Dr. Behlke (together with Dr. John Rossi, from the Beckman Research Institute at the City of Hope) is a scientific co-founder of Dicerna Pharmaceuticals, located in Boston, Massachusetts and is a member of the Dicerna Scientific Advisory Board.

Before joining IDT, Dr. Behlke was a Physician Postdoctoral Fellow of the Howard Hughes Medical Institute at the Whitehead Institute for Biomedical Research, MIT, where he studied human sex determination in the laboratory of Dr. David Page. He was a Resident Physician in Internal Medicine and Fellow in Endocrinology at Brigham and Women’s Hospital, Boston.

Dr. Behlke received his M.D. and Ph.D. degrees from Washington University, St. Louis in 1988, where he studied immunogenetics in the laboratory of Dr. Dennis Loh. He received his B.S. degree from the Massachusetts Institute of Technology in 1981.

**********************
**************
 
For speaker's contact information - Contact us

Specialties

Biotechnology

Interested Topics

Biotechnology, Research and Development, Clinical Research, Clinical Trials, Immunology and Microbiology, Immunogenetics, Genomics, Life Science, Biochemistry, Endocrinology, Medicine

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message